Erschienen in:
22.11.2017 | Breast Oncology
Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial
verfasst von:
Emmanuel Barranger, MD, PhD, Tarik Ihrai, MD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2017
Einloggen, um Zugang zu erhalten
Excerpt
The standard practice in breast cancer surgery is to mandate a sentinel node biopsy (SNB) for all patients without clinically negative axillary lymph node. To date, the “gold standard” for detecting the sentinel lymph node (SLN) is a combination of blue dye and radioisotope.
1 However, in recent years, the use of these tracers has been controversial because of allergic complications involving blue dye and organizational difficulties regarding the radioisotopic method. This has led some teams to develop new tracers for SLN localization. Thus, a magnetic tracer was recently developed to replace potentially one of two commonly used tracers. …